Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Intra-Cellular Therapies ...

    NASDAQ: ITCI · Real-Time Price · USD
    131.87
    0.00 (0.00%)
    At close: Apr 01, 2025, 3:59 PM

    Intra-Cellular Therapies Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 680.85M 464.37M 249.13M 81.71M
    Cost of Revenue
    		 56.96M 33.74M 20.44M 8.03M
    Gross Profit
    		 623.89M 430.63M 228.69M 73.67M
    Operating Income
    		 -116.72M -159.38M -263.63M -285.69M
    Interest Income
    		 42.52M 20.34M 7.38M 1.57M
    Pretax Income
    		 -74.2M -139.04M -256.25M -284.12M
    Net Income
    		 -74.68M -139.67M -256.26M -284.13M
    Selling & General & Admin
    		 504.49M 409.86M 358.78M 272.61M
    Research & Development
    		 236.12M 180.14M 134.72M 88.85M
    Other Expenses
    		 n/a n/a -1.18M -2.1M
    Operating Expenses
    		 740.61M 590.01M 492.31M 359.36M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 92.2M 85.8M 82.5M
    Cost & Expenses
    		 797.57M 623.75M 512.76M 367.4M
    Income Tax Expense
    		 473K 636K 6K 5.63K
    Shares Outstanding (Basic)
    		 103.13M 95.88M 94.05M 81.25M
    Shares Outstanding (Diluted)
    		 103.13M 95.88M 94.05M 81.25M
    EPS (Basic)
    		 -0.72 -1.46 -2.72 -3.5
    EPS (Diluted)
    		 -0.72 -1.46 -2.72 -3.5
    EBITDA
    		 -116.72M -158.85M -262.97M -285.15M
    EBIT
    		 -116.72M -159.38M -263.63M -285.69M
    Depreciation & Amortization
    		 n/a 528K 656K 533.36K

    Add to Watchlist